Calcium and neurodegeneration

Aging Cell

Volumn 6, Issue 3, 2007, Pages 337-350

  Mattson, Mark R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Amyloid; Apoptosis; Endoplasmic reticulum; N methyl d aspartate; Parkinson's disease; Presenilin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; APOLIPOPROTEIN E; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHELATING AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; CURCUMIN; GLUCOSE TRANSPORTER; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; HUNTINGTIN; MEMANTINE; MEMBRANE PROTEIN; MULTIENZYME COMPLEX; NIMODIPINE; PRESENILIN 1; PROTEIN BCL 2; PROTEIN HERP; RECEPTOR PROTEIN; RESVERATROL; RILUZOLE; RYANODINE RECEPTOR; SULFORAPHANE; TOXIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; VOLTAGE GATED CALCIUM CHANNEL;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CALORIC INTAKE; CELL COMPARTMENTALIZATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MODIFICATION; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXCITOTOXICITY; EXERCISE; GENE MUTATION; HEREDITY; HORMESIS; HUMAN; HUNTINGTON CHOREA; LIFESTYLE; MOLECULAR DYNAMICS; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; RISK FACTOR; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; UNSPECIFIED SIDE EFFECT;

AMYLOID; ANIMALS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PARKINSON DISEASE; PRESENILINS;

EID: 34249092704     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2007.00275.x     Document Type: Review

References (197)

1. Abou-Sleiman PM, Muqit MM, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7, 207-219.
2. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 4217-4221.
3. Alexianu ME, Ho BK, Mohamed AD, La Bella V, Smith RG, Appel SH (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36, 846-858.
4. Altar CA, Laeng P, Jurata LW, Brocman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, Palfreyman MG (2004) Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 24, 2667-2677.
5. Anitha M, Gondha C, Sutliff R, Parsadanian A, Mwangi S, Sitaraman SV, Srinivasan S (2006) GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest. 116, 344-356.
6. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
7. Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H (2004) Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15, 1751-1754.
8. Arumugam TV, Gleichmann M, Tang SC, Mattson MP (2006) Hormesis/ preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev. 5, 165-178.
9. Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34, 325-337.
10. 2+ accumulation. Proc. Natl Acad. Sci. USA 92, 9328-9332.
11. Barger SW, Mattson MP (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40, 116-126.
12. Bartschat DK, Rhodes TE (1995) Protein kinase C modulates calcium channels in isolated presynaptic nerve terminals of rat hippocampus. J. Neurochem. 64, 2064-2072.
13. Beal MF (1998a) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
14. Beal MF (1998b) Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann. Neurol. 44, S110-S114.
15. Beers DR, Ho BK, Siklos L, Alexianu ME, Mosier DR, Mohamed AH, Otsuka Y, Kozovska ME, McAlhany RE, Smith RG, Appel SH (2001) Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 79, 499-509.
16. Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
17. Bezprozvanny I, Hayden MR (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem. Biophys. Res. Commun. 322, 1310-1317.
18. Blanc EM, Keller JN, Fernandez S, Mattson MP (1998) 4-Hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes. Glia 22, 149-160.
19. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881.
20. 2+-sensor proteins: From Alzheimer's disease to cancer. Trends Pharmacol. Sci. 26, 345-351.
21. Bruce-Keller AJ, Umberger G, McFall R, Mattson MP (1999) Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45, 8-15.
22. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749.
23. Brustovetsky N, LaFrance R, Purl KJ, Brustovetsky T, Keene CD, Low WC, Dubinsky JM (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease. J. Neurochem. 93, 1361-1370.
24. Bullock R (2006) Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: The evidence to date. Alzheimer Dis. Assoc. Disord. 20, 23-29.
25. 2+ buffers and synaptic efficacy. Cell Calcium 37, 489-495.
26. Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26, 739-764.
27. Camandola S, Cutler RG, Gary DS, Milhavet O, Mattson MP (2005) Suppression of calcium release from inositol 1,4,5-trisphosphate-sensitive stores mediates the anti-apoptotic function of nuclear factor-κB. J. Biol. Chem. 280, 22287-22296.
28. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA (1996) Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272, 542-545.
29. 2+ homeostasis and mitochondrial function during endoplasmic reticulum stress. J. Biol. Chem. 279, 28733-28743.
30. Chan SL, Furukawa K, Mattson (2002) Presenilins and APP in neuritic and synaptic plasticity: Implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med. 2, 167-196.
31. Chan SL, Mattson MP (1999) Caspase and calpain substrates: Roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167-190.
32. Cheng B, Furukawa K, O'Keefe JA, Goodman Y, Kihiko M, Fabian T, Mattson MP (1995) Basic fibroblast growth factor selectively increases AMPA-receptor subunit GluR1 protein level and differentially modulates Ca 2+ responses to AMPA and NMDA in hippocampal neurons. J. Neurochem. 65, 2525-2536.
33. Cheng B, Mattson MP (1991) NGF and bFGF protect rat and human central neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
34. Cheng B, Mattson MP (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12, 1558-1566.
35. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640, 56-67.
36. Collins RC, Dobkin BH, Choi DW (1989) Selective vulnerability of the brain: New insights into the pathophysiology of stroke. Ann. Intern. Med. 110, 992-1000.
37. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331, 761-777.
38. Cutler RG, Kelly J, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 2070-2075.
39. Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in ALS. Ann. Neurol. 52, 448-457.
40. Dargusch R, Paisecki D, Tan S, Liu Y, Schubert D (2001) The role of Bax in glutamate-induced nerve cell death. J. Neurochem. 76, 295-301.
41. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
42. Drew B, Leeuwenburgh C (2004) Ageing and subcellular distribution of mitochondria: Role of mitochondrial DNA deletions and energy production. Acta Physiol. Scand. 182, 333-341.
43. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression and increases survival in Huntingtin mutant mice. Proc. Natl Acad. Sci. USA 100, 2911-2916.
44. Duan W, Guo Z, Mattson MP (2001) Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J. Neurochem. 76, 619-626.
45. Duan W, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195-206.
46. Duan W, Rangnekar VM, Mattson MP (1999) Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: Evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72, 2312-2322.
47. Duchen MR (2000) Mitochondria and calcium: From cell signalling to cell death. J. Physiol. 529, 57-68.
48. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl Acad. Sci. USA 101, 11159-11164.
49. Endres M, Gertz K, Lindauer U, Katchanov J, Schultze J, Schrock H, Nickenig G, Kuschinsky W, Dirnagl U, Laufs U (2003) Mechanisms of stroke protection by physical activity. Ann. Neurol. 54, 582-590.
50. Fawcett JP, Alonso-Vanegas MA, Morris SJ, Miller FD, Sadikot AF, Murphy RA (2000) Evidence that brain-derived neurotrophic factor from presynaptic nerve terminals regulates the phenotype of calbindin-containing neurons in the lateral septum. J. Neurosci. 20, 274-282.
51. Firdaus WJ, Wyttenbach A, Diaz-Latoud C, Currie RW, Arrigo AP (2006) Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant. FEBS J. 273, 3076-3093.
52. Floyd RA, Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795-807.
53. Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792 (QS-21)-201 Study (2005) Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64, 1563-1572.
54. 2+ release from intracellular stores in cultured cerebral cortical neurons. J. Neurochem. 56, 1075-1078.
55. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, Mattson MP (1997) The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178-8186.
56. Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N, Itoyama Y, Wang Y, Yao PJ, Bushlin I, Takeda A (2006) Plasma membrane ion permeability induced by mutant α-synuclein contributes to the degeneration of neural cells. J. Neurochem. 97, 1071-1077.
57. Furukawa K, Mattson MP (1998) The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA and AMPA/ kainate-induced currents in response to TNF-a in hippocampal neurons. J. Neurochem. 70, 1876-1886.
58. Furukawa K, Wang Y, Yao P, Fu W, Mattson MP, Itoyama Y, Onodera H, D'Souza I, Poorkaj P, Bird D, Schellenberg GD (2003) Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J. Neurochem. 87, 427-436.
59. Gao X, Talalay P (2004) Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl Acad. Sci. USA 101, 10446-10451.
60. Gardian G, Vecsei L (2004) Huntington's disease: Pathomechanism and therapeutic perspectives. J. Neural. Transm. 111, 1485-1494.
61. Gelinas DS, DaSilva K, Fenili D, St George-Hyslop P, McLaurin J (2004) Immunotherapy for Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, S14657-S14662.
62. Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y, Sapolsky R, Steinberg G, Hu B, Yenari MA (2004) Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J. Exp. Biol. 207, 3213-3220.
63. Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM; AN1792 (QS-21)-201 Study Team (2005) Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64, 1553-1562.
64. Gobbo OL, O'Mara SM (2005) Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor. Behav. Brain Res. 159, 21-26.
65. Greenamyre JT, MacKenzie G, Peng TI, Stephans SE (1999) Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 66, 85-97.
66. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718-724.
67. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5, 101-107.
68. Guo Z, Kindy MS, Kruman I, Mattson MP (2000) ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury. J. Cereb. Blood Flow Metab. 20, 463-468.
69. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: Involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
70. Hartmann H, Eckert A, Muller WE (1994) Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to β-amyloid neurotoxicity. Biochem. Biophys. Res. Commun. 200, 1185-1192.
71. 2+ signaling in Purkinje neurons. Cell Calcium 37, 459-466.
72. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd R, Butterfield DA (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl Acad. Sci. USA 91, 3270-3274.
73. Hof PR, Glezer II, Conde F, Flagg RA, Rubin MB, Nimchinsky EA, Vogt Weisenhorn DM (1999) Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: Phylogenetic and developmental patterns. J. Chem. Neuroanat. 16, 77-116.
74. Hong SC, Goto Y, Lanzino G, Soleau S, Kassell NF, Lee KS (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669.
75. Huynh DP, Scoles DR, Nguyen D, Pulst SM (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12, 2587-2597.
76. Hyun DH, Hernandez JO, Mattson MP, de Cabo R (2006) The plasma membrane redox system in aging. Ageing Res. Rev. 5, 209-220.
77. Ingall T (2004) Stroke - incidence, mortality, morbidity and risk. J. Insur. Med. 36, 143-152.
78. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 25, 5217-5224.
79. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62, 1220-1227.
80. Jensen MS, Ahlemeyer B, Ravati A, Thakur P, Mennel HD, Krieglstein J (2002) Preconditioning-induced protection against cyanide-induced neurotoxicity is mediated by preserving mitochondrial function. Neurochem. Int. 40, 285-293.
81. Kasarskis EJ, Tandon L, Lovell MA, Ehmann WD (1995) Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: A preliminary study. J. Neurol. Sci. 130, 203-208.
82. Kawahara M, Kuroda Y (2000) Molecular mechanism of neurodegeneration induced by Alzheimer's β-amyloid protein: Channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53, 389-397.
83. Kegel KB, Sapp E, Yoder J, Cuiffo B, Sobin L, Kim YJ, Qin ZH, Hayden MR, Aronin N, Scott DL, Isenberg G, Goldmann WH, DiFiglia M (2005) Huntingtin associates with acidic phospholipids at the plasma membrane. J. Biol. Chem. 280, 36464-36473.
84. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687-697.
85. Keller JN, Mark RJ, Bruce AJ, Blanc EM, Rothstein JD, Uchida K, Mattson MP (1997a) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685-696.
86. Kirino T (2002) Ischemic tolerance. J. Cereb. Blood Flow Metab. 22, 1283-1296.
87. Kristian T, Siesjo BK (1998) Calcium in ischemic cell death. Stroke 29, 705-718.
88. Kruman II, Mattson MP (1999) Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72, 529-540.
89. Kruman II, Pedersen WA, Springer JE, Mattson MP (1999) ALS-linked Cu/ Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160, 28-39.
90. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
91. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 120, 701-713.
92. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, Mattson MP (1999) 2-Deoxy-d-glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins. J. Neurosci. Res. 57, 48-61.
93. Lee HJ, Choi C, Lee SJ (2002d) Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678.
94. Lee J, Duan W, Mattson MP (2002b) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82, 1367-1375.
95. Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002c) Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. USA 99, 8968-8973.
96. Lee HM, Wang C, Hu Z, Greeley GH, Makalowski W, Hellmich HL, Englander EW (2002a) Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain. J. Neurochem. 80, 928-937.
97. Leist M, Fava E, Montecucco C, Nicotera P (1997) Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9, 1488-1498.
98. Leonard AS, Bayer KU, Mrrill MA, Lim IA, Shea MA, Schulman H, Hell JW (2002) Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-d-aspartate receptors by calcium/calmodulin and α-actinin. J. Biol. Chem. 277, 48441-48448.
99. 2+, mitochondria and selective motoneuron vulnerability: Implications for ALS. Trends Neurosci. 28, 494-500.
100. Li C, Li PA, He QP, Ouyang YB, Siesjo BK (1998) Effects of streptozotocin-induced hyperglycemia on brain damage following transient ischemia. Neurobiol. Dis. 5, 117-128.
101. Liang ZQ, Wang XX, Wang Y, Chuang DM, DiFiglia M, Chase TN, Qin ZH (2005) Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity. Neurobiol. Dis. 20, 562-573.
102. Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ. 13, 385-392.
103. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ, Loscaizo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
104. Liu D, Chan SL, de Souza-Pinto NC, Slevin JR, Wersto RP, Zhan M, Mustafa K, de Cabo R, Mattson MP (2006) Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Med. 8, 389-414.
105. Liu J, Narasimhan PYuF, Chan PH (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36, 1264-1269.
106. Lo Bionco C, Ridet JL, Schneider BL, Deglon N, Aebisher P (2002) α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl Acad. Sci. USA 99, 10813-10818.
107. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
108. Lu WY, Jackson MF, Bai D, Orser BA, MacDonald JF (2000) In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors. J. Neurosci. 20, 4452-4461.
109. Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 5644-5651.
110. Maragos WF, Korde AS (2004) Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury. J. Neurochem. 91, 257-262.
111. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
112. +-ATPase activity in hippocampal neurons. Brain Res. 756, 205-214.
113. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997a) A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
114. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
115. Martin B, Mattson MP, Maudsley S (2006) Caloric restriction and intermittent fasting: Two potential diets for successful brain aging. Ageing Res. Rev. 5, 332-353.
116. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP, Ingram DK (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101, 18171-18176.
117. 2+ influx in cultured hippocampal neurons. Neuron 4, 105-117.
118. Mattson MP (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21, 53-57.
119. Mattson MP (2003) Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 3, 65-94.
120. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
121. Mattson MP, Barger SW, Cheng B, Lieberburg I, Smith-Swintosky VL, Rydel RE (1993c) β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415.
122. Mattson MP, Chan SL (2003) Good and bad amyloid antibodies. Science 301, 1847-1849.
123. Mattson MP, Cheng A (2006) Neurohormetic phytochemicals: Low dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29, 632-639.
124. Mattson MP, Cheng B, Culwell A, Esch F, Lieberburg I, Rydel RE (1993a) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254.
125. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
126. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
127. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J. 3, 2519-2526.
128. Mattson MP, Kroemer G (2003) Mitochondria in cell death: Novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9, 196-205.
129. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
130. Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278-294.
131. Mattson MP, Murrain M, Guthrie PB, Kater SB (1989a) Fibroblast growth factor and glutamate: Opposing actions in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
132. Mattson MP, Rychlik B, Chu C, Christakos S (1991) Evidence for calcium-reducing and excitoprotective roles for the calcium binding protein (calbindin-D28k) in cultured hippocampal neurons. Neuron 6, 41-51.
133. Mattson MP, Sherman M (2003) Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation. Neuromolecular Med. 4, 109-132.
134. Mattson MP, Zhang Y, Bose S (1993b) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121, 1-13.
135. Mattson MP, Zhu HYuJ, Kindy MS (2000) Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis. J. Neurosci. 20, 1358-1364.
136. Mayeux R (2003) Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26, 81-104.
137. Miller RG, Mitchell JD, Lyon M, Moore DH (2003) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4, 191-206.
138. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 27, 57-87.
139. Mouatt-Prigent A, Agid Y, Hirsch EC (1994) Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? Brain Res. 668, 62-70.
140. Moulder KL, Onodera O, Burke JR, Strittmatter WJ, Johnson EM Jr (1999) Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length. J. Neurosci. 19, 705-715.
141. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G (1996) Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl Acad. Sci. USA 93, 9893-9898.
142. 2+-mediated mitochondrial dysfunction in neural cell death. Biochem. Soc. Symp. 66, 33-41.
143. Murray FE, Landsberg JP, Williams RJ, Esiri MM, Watt F (1992) Elemental analysis of neurofibrillary tangles in Alzheimer's disease using proton-induced X-ray analysis. Ciba Found. Symp. 169, 201-210.
144. Navarro A (2004) Mitochondrial enzyme activities as biochemical markers of aging. Mol. Aspects Med. 25, 37-48.
145. Nellgard B, Wieloch T (1992) Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp. Brain Res. 92, 259-266.
146. Nicholls DG, Vesce S, Kirk L, Chalmers S (2003) Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34, 407-424.
147. Nitta A, Murai R, Suzuki N, Ito H, Nomoto H, Katoh G, Furukawa Y, Furukawa S (2002) Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol. Teratol. 24, 695-701.
148. Nixon RA (2003) The calpains in aging and aging-related diseases. Ageing Res. Rev. 2, 407-418.
149. 2+ influx through voltage-dependent calcium channels. J. Neurochem. 76, 341-350.
150. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 6048-6054.
151. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349-350.
152. Paschen W (2003) Endoplasmic reticulum: A primary target in various acute disorders and degenerative diseases of the brain. Cell Calcium 34, 365-383.
153. Patel NV, Gordon MN, Connor KE, Good RA, Engelman RW, Mason J, Morgan DG, Morgan TE, Finch CE (2005) Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models. Neurobiol. Aging 26, 995-1000.
154. Pedersen WA, Chan SL, Mattson MP (2000) A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74, 1426-1433.
155. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel SH, Smith RG, Kasarskis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in spinal cord tissue of ALS patients. Ann. Neurol. 44, 819-824.
156. Pedersen WA, Mattson MP (1999) No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/ Zn-superoxide dismutase mutant mice. Brain Res. 833, 117-120.
157. Perez-Navarro E, Arenas E, Reiriz J, Calvo N, Alberch J (1996) Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience 75, 345-352.
158. Polster BM, Fiskum G (2004) Mitochondrial mechanisms of neural cell apoptosis. J. Neurochem. 90, 1281-1289.
159. Poon HF, Calabrese V, Scapagnini G, Butterfield DA (2004) Free radicals and brain aging. Clin. Geriatr. Med. 20, 329-359.
160. Przedborski S, Ischiropoulos H (2005) Reactive oxygen and nitrogen
161. Ramsden M, Berchtold NC, Patrick Kesslak J, Cotman CW, Pike CJ (2003) Exercise increases the vulnerability of rat hippocampal neurons to kainate lesion. Brain Res. 971, 239-244.
162. Rodriguez-Pena A, Botana M, Gonzalez M, Requejo F (1995) Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci. Lett. 1, 37-40.
163. Saito A, Maier CM, Narasimhan P, Nishi T, Song YS, Yu F, Liu J, Lee YS, Nito C, Kamada H, Dodd RL, Hsieh LB, Hassid B, Kim EE, Gonzalez M, Chan PH (2005) Oxidative stress and neuronal death/survival signaling in cerebral ischemia. Mol. Neurobiol. 31, 105-116.
164. Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage. J. Neurosci. 22, 7006-7015.
165. Simpson EP, Mosier D, Appel SH (2002) Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. Adv. Neurol. 88, 1-19.
166. Smith RG, Henry YK, Mattson MP, Appel SH (1998) Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 44, 696-699.
167. Smith AD, Zigmond MJ (2003) Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Exp. Neurol. 184, 31-39.
168. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE (2006) Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26, 4509-4518.
169. Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J. Neurosci. 24, 2270-2276.
170. Springer JE, Azbill RD, Nottingham SA, Kennedy SE (2000) Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci. 20, 7246-7251.
171. Stefanis L (2005) Caspase-dependent and -independent neuronal death: Two distinct pathways to neuronal injury. Neuroscientist 11, 50-62.
172. Stein-Behrens B, Mattson MP, Chang I, Yeh M, Sapolsky R (1994) Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373-5380.
173. Stern Y (2006) Cognitive reserve and Alzheimer disease. Alzheimer Dis. Asso. c Disord. 2006, 20: S69-S74.
174. 2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 26, 5180-5189.
175. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl Acad. Sci. USA 102, 2602-2607.
176. Tateno M, Sadakata H, Tanaka M, Itohara S, Shin RM, Miura M, Masuda M, Aosaki T, Urushitani M, Misawa H, Takahashi R (2004) Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum. Mol. Genet. 13, 2183-2196.
177. Tolar M, Keller JN, Chan SL, Mattson MP, Marques MA, Crutcher KA (1999) Truncated apolipoprotein E (ApoE) causes increased intra-cellular calcium and may mediate ApoE neurotoxicity. J. Neurosci. 19, 7100-7110.
178. Tollefson GD (1990) Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia. Biol. Psychiatry 27, 1133-1142.
179. Tomac AC, Agulnick AD, Haughey N, Chang CF, Zhang Y, Backman C, Morales M, Mattson MP, Wang Y, Westphal H, Hoffer BJ (2002) Effects of cerebral ischemia in mice deficient in Persephin. Proc. Natl Acad. Sci. USA 99, 9521-9526.
180. Turski L, Bressler K, Rettig KJ, Loschmann PA, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists. Nature 349, 414-418.
181. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11, 221-235.
182. Van Damme P, Dewil M, Robberecht W, Van den Bosch L (2005) Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener Dis. 2, 147-159.
183. Vannucci SJ, Willing LB, Goto S, Alkayed NJ, Brucklacher RM, Wood TL, Towfighi J, Hurn PD, Simpson IA (2001) Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 21, 52-60.
184. Vaynman S, Gomez-Pinilla F (2006) Revenge of the 'sit': How lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. J. Neurosci. Res. 84, 699-715.
185. Volles MJ, Lansbury PT Jr (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595-4602.
186. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM (2005a) Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 19, 659-661.
187. Wang Y, Mattson MP, Furukawa K (2002) Endoplasmic reticulum calcium release is modulated by actin polymerization. J. Neurochem. 82, 945-952.
188. Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, MacDonald RS, Miller DK, Lubahn DE, Weisman GA, Sun GY (2005b) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 82, 138-148.
189. Weiss JH, Hartley DM, Koh J, Choi DW (1990) The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 247, 1474-1477.
190. Werth JL, Thayer SA (1994) Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J. Neurosci. 14, 348-356.
191. Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526, 303-307.
192. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696-2701.
193. Young D, Lawlor PA, Leone P, Dragunow M, During MJ (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat. Med. 5, 448-453.
194. Yu Z, Luo H, Fu W, Mattson MP (1999) The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: Suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155, 302-314.
195. Yu ZF, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism. J. Neurosci. Res. 57, 830-839.
196. Yuste R, Majewska A, Holthoff K (2000) From form to function: Calcium compartmentalization in dendritic spines. Nat. Neurosci. 3, 653-659.
197. Zhu H, Guo Q, Mattson MP (1999) Dietary restriction protects hippo-campal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842, 224-229.